Mobile coronavirus testing units for frontline workers
Mobile coronavirus testing units, operated by the Armed Forces, will travel around the UK to increase access to coronavirus testing. Essential workers and the most...
Medicspot rolls out remote COVID-19 diagnosis system
Medicspot is rolling out the technology for remote COVID-19 diagnosis to protect staff and patients amid the COVID-19 outbreak. Working in partnership with clinical commissioning...
NICE coronavirus guidelines on gastrointestinal and liver conditions and acute myocardial injuries
NICE has published two new rapid coronavirus guidelines on the care of patients with suspected and confirmed COVID-19. They cover the management of disorders of...
New data shows varied state of haemophilia treatment around the world
To mark the 30th Anniversary of World Haemophilia Day, Sobi have released the 2020 Haemophilia Index which shows the varied state of haemophilia treatment...
Cegedim launches free pharmacist training during COVID-19
Cegedim launches free digital training to help pharmacists deliver ongoing care throughout COVID-19. Cegedim Rx, part of the innovative healthcare technology and services company, Cegedim,...
Advice on ibuprofen and coronavirus (COVID-19): Commission on Human Medicines
The Commission of Human Medicines (CHM) Expert Working Group on coronavirus (COVID-19) has given its advice on ibuprofen and coronavirus (COVID-19). It concluded that there is...
Interactive tool shows the science behind COVID-19 control measures
An online tool to illustrate the effects of different COVID-19 control measures has been developed by a team of University of Cambridge researchers. The ‘lowhighcovid’...
NICE COVID-19 guidelines for cystic fibrosis, COPD and dermatological conditions
NICE has published three more rapid guidelines on the care of patients with suspected and confirmed COVID-19, and in patients without COVID-19. They cover...
Private hospital merger to be approved if local concerns addressed
The CMA has found that the completed private hospital merger between Circle and BMI does not raise UK-wide competition concerns but could reduce competition...
NICE COVID-19 guidelines: severe asthma, pneumonia, rheumatological disorders, symptom management
New NICE COVID-19 guidelines have been published on severe asthma, pneumonia, rheumatological disorders and symptom management in community settings. NICE has published the four new...
Latest articles
Pf Webinar: Adopting Agile in pharma for more effective cross-functional marketing teamwork
Pf is proud to announce the second instalment of the FREE webinar series with Triducive. This webinar focuses on Agile and how it can...
New Patient Recruitment Centres for late-phase clinical research
NHS patients will benefit from easier access to clinical research opportunities, following a £7m government investment to launch five new regional Patient Recruitment Centres...
NICE recommends new triple negative breast cancer treatment
Draft guidance published today by the National Institute for Health and Care Excellence (NICE) recommends Roche's Tecentriq®▼ (atezolizumab) for treating people with a type...
Popular articles
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
NHS roadmap to safely bring back routine operations during COVID-19
Health leaders have set out a series of measures to help local hospitals plan to increase routine operations and treatment, while keeping the necessary...
Roche develops new COVID-19 antibody test
Roche has announced the development and upcoming launch of a new COVID-19 antibody test. Its Elecsys® Anti-SARS-CoV-2 serology test will detect antibodies in people...
Kate Bingham appointed Chair of UK Vaccine Taskforce
Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
BIVDA comments on Roche COVID-19 antibody test authorisation
The British In Vitro Diagnostics Association (BIVDA) has commented on the Roche COVID-19 antibody test authorisation by Public Health England. BIVDA is delighted to see...